Silver Book Fact

Adjusted to the U.S. 2000 population, the prevalence of valve disease was 2.5% and the mortality risk ratio associated with the disease was 1.36.

Nkomo V, Gardin J, Skelton T, Gottdiener J, et al. Burden of Valvular Heart Diseases: A population-based study. Lancet. September 2006; 368(9540): 1005-11. http://www.ncbi.nlm.nih.gov/pubmed/16980116

Reference

Title
Burden of Valvular Heart Diseases: A population-based study
Publication
Lancet
Publication Date
September 2006
Authors
Nkomo V, Gardin J, Skelton T, Gottdiener J, et al.
Volume & Issue
Volume 368, Issue 9540
Pages
1005-11
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • In-hospital deaths caused by venous thromboembolism
    The number of in-hospital deaths that are caused by venous thromboembolism is more than five times the number of deaths caused by all hospital-acquired infections.  
  • The direct medical costs and indirect costs in loss of productivity of heart disease and stroke in the U.S. was estimated at $315.4 billion in 2010.  
  • In 2006, $32.7 billion in program payments were made to Medicare beneficiaries discharged from short-stay hospitals with a principal diagnosis of cardiovascular disease–and average of $10,201 per discharge.  
  • From 2010 to 2030, the total direct medical costs of cardiovascular disease (in 2008 dollars) are projected to triple–from $273 billion to $818 billion.  
  • The prognosis for patients with heart failure is worse than with most forms of cancer, and median survival rates are less than 5 years.